On September 7, 2021 Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported that it will be presenting at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference (Press release, Aethlon Medical, SEP 7, 2021, https://www.prnewswire.com/news-releases/aethlon-medical-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301370027.html [SID1234587350]). The conference is being held virtually from September 13-15, 2021.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Charles J. Fisher, M.D., Chief Executive Officer, will present an overview of Aethlon Medical the conference. The presentation will be available on-demand beginning Monday, September 13 at 7:00 AM EDT at the link below and will be archived for 90 days. It will also be available on the Aethlon website. In addition to the overview presentation, Dr. Fisher will be hosting virtual one-on-one meetings at the conference on Monday, September 13.
Event: H.C. Wainwright 23rd Annual Global Investment Conference (Virtual Conference)
Date: September 13, 2021
Time: 7:00 AM EDT
Location: Virtual Conference
Company Webcasting Link: View Source